REG - Induction Healthcare - Material new contract & Notice of Interim Results

Induction HealthcareAnnouncement

30/10/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241030:nRSd1326Ka&default-theme=true

RNS Number : 1326K  Induction Healthcare Group PLC  30 October 2024

INDUCTION HEALTHCARE GROUP PLC

 

Material new contract with North Central London Integrated Care System

Notice of Interim Results and Investor Presentation

 

London, UK - 30 October 2024: Induction Healthcare Group PLC ("Induction", the
"Company", or the "Group"; AIM: INHC), a leading digital health platform
driving transformation of healthcare systems, has signed a contract worth
£1.5m to transform patient access to diagnostic tests across the North
Central London Integrated Care System.

 

This project will deliver significant enhancements to Induction's integrated
platform which will connect the Royal Free London NHS Foundation Trust,
Whittington Health NHS Trust, and their corresponding Community Diagnostics
Centres in Wood Green and Finchley. The platform will digitise diagnostic
referrals and booking and will:

 

·       Allow for integrated electronic referrals between the different
electronic patient record systems used across the Integrated Care System
("ICS");

·      Give Trusts direct access to Community Diagnostic Centre
appointment slots to book tests directly for patients;

·      Enable patients to manage and self-book their diagnostic tests,
as well as access information about their visit;

·      Collect data on patient 'no shows' to provide insight on
initiatives to reduce missed appointments; and

·      Allow smart scheduling (including same-day and multi-modality
bookings) to be created and managed.

 

Induction CEO, Paul Tambeau, said: "Induction will be the first portal
provider to integrate disparate electronic systems across a region to
facilitate diagnostic tests for patients, while at the same time giving
patients greater control over their care. Induction will own the platform IP.
Digitising and individualising care pathways across an ICS aligns with our
renewed corporate strategy, and we believe that this contract provides a basis
for growth into the future. I look forward to providing a trading update with
the Interim results on 5 November."

 

Induction is delivering this as a professional services contract to fund
platform development, given that the functionality will be relevant to many
other Integrated Care Systems. The majority of the revenue will be recognised
in FY25.

 

 

Interim Results

Induction will release Interim Results for the 6 months ended 30 September
2024 on 5 November 2024. Paul Tambeau, CEO, and John McIntosh, CFO, will
provide a live presentation via Investor Meet Company on 05 Nov 2024, 15:00
GMT. The presentation is open to all existing and potential shareholders.
Questions can be submitted pre-event via your Investor Meet Company dashboard
up until 04 Nov 2024, 09:00 GMT, or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet
INDUCTION HEALTHCARE GROUP PLC via:
https://www.investormeetcompany.com/induction-healthcare-group-plc/register-investor.
Investors who already follow Induction on the Investor Meet Company platform
will automatically be invited.

 

 

Enquiries

 

 Induction

 Christopher Samler, Chair                              +44 (0)7712 194092

 Paul Tambeau, Chief Executive Officer                  +44 (0)7983 104443

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0)20 7496 3000
 Philip Davies

 Jalini Kalaravy

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com/)

Induction (AIM: INHC) Induction delivers a suite of software solutions that
transforms care delivery and the patient journey through hospital. Our
system-wide applications help healthcare providers and administrators to
deliver care at any stage remotely as well as face-to-face - giving the
communities they serve greater flexibility, control and ease of access.
Purpose-built for integration with leading Electronic Medical Record (EMR)
platforms, our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOREAAENAFLLFAA